Ixekizumab versus FAEs and methotrexate in treatment of nail psoriasis in patients with moderate-to-severe psoriasis

被引：1

作者：

Augustin, Matthias ^{[1
,9
]}

Mrowietz, Ulrich ^{[2
]}

Willsmann-Theis, Dagmar ^{[3
]}

Gerdes, Sascha ^{[2
]}

Fotiou, Konstantinos ^{[4
]}

Schuster, Christopher ^{[4
,5
]}

Mert, Can ^{[6
]}

Holzkaemper, Thorsten ^{[4
]}

Behrens, Frank ^{[7
]}

Pinter, Andreas ^{[8
]}

机构：

[1] Univ Med Ctr Hamburg Eppendorf UKE, Inst Hlth Serv Res Dermatol & Nursing IVDP, German Ctr Hlth Serv Res Dermatol, Hamburg, Germany

[2] Univ Med Ctr Schleswig Holstein, Psoriasis Ctr, Dept Dermatol, Campus Kiel, Kiel, Germany

[3] Univ Hosp Bonn, Clin & Polyclin Dermatol & Allergol, Bonn, Germany

[4] Eli Lilly & Co, Indianapolis, IN USA

[5] Med Univ Vienna, Dept Dermatol, Vienna, Austria

[6] HaaPACS GmbH, Schriesheim, Germany

[7] Goethe Univ Frankfurt, Ctr Innovat Diagnost & Therapy Rheumatol Immunol, Frankfurt, Germany

[8] Univ Hosp Frankfurt, Dept Dermatol Venereol & Allergol, Frankfurt, Germany

[9] Univ Med Ctr Hamburg Eppendorf, German Ctr Hlth Serv Res Dermatol, Martinistr 52, D-20246 Hamburg, Germany

来源：

JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT | 2024年

关键词：

EFFICACY;

D O I：

10.1111/ddg.15292

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

引用

页数：4

共 50 条

[31] Ixekizumab provides persistent improvement in the symptoms of genital psoriasis through one year of treatment in patients with moderate-to-severe genital psoriasis
Ryan, C.
Burge, R.
Poulin, Y.
Spelman, L.
Bleakman, A. Potts
Yang, F. E.
Bertram, C. C.
Guenther, L.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2019, 33 : 31 - 31
[32] INFLIXIMAB BIOSIMILAR VERSUS METHOTREXATE FOR THE TREATMENT OF MODERATE TO SEVERE PSORIASIS
Sarbu, Maria-Isabela
Tampa, Mircea
Matei, Clara
Mitran, Cristina-Iulia
Mitran, Madalina-Irina
Pituru, Silviu
Pop, Corina Silvia
Saramet, Gabriel
Georgescu, Simona-Roxana
FARMACIA, 2017, 65 (06) : 962 - 967
[33] Ixekizumab treatment improves nail psoriasis in patients with moderate-to-severe psoriasis: results from the randomized and controlled as well as open-label phases of UNCOVER-3
van de Kerkhof, P.
Guenther, L.
Gottlieb, A.
Sebastian, M.
Wu, J.
Foley, P.
Morita, A.
Goldblum, O.
Zhang, L.
Erickson, J.
Ball, S.
Rich, P.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2016, 30 : 69 - 69
[34] Tofacitinib for the treatment of moderate-to-severe psoriasis
Chiricozzi, Andrea
Faleri, Sara
Saraceno, Rosita
Bianchi, Luca
Buonomo, Oreste
Chimenti, Sergio
Chimenti, Maria Sole
EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2015, 11 (04) : 443 - 455
[35] Early identification of response with methotrexate for moderate-to-severe psoriasis
Gordon, K.
Sundaram, M.
Arunajadai, S.
Xie, M.
Signorovitch, J.
Betts, K.
Okun, M.
BRITISH JOURNAL OF DERMATOLOGY, 2014, 171 (06) : E153 - E153
[36] Tailored biological treatment for patients with moderate-to-severe psoriasis
Maurelli, Martina
Gisondi, Paolo
Girolomoni, Giampiero
EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2023, 19 (01) : 37 - 43
[37] Treatment of moderate-to-severe plaque psoriasis
Salgo, R.
Thaci, D.
GIORNALE ITALIANO DI DERMATOLOGIA E VENEREOLOGIA, 2009, 144 (06): : 701 - 711
[38] Liver fibrosis is independent of methotrexate use in patients with moderate-to-severe psoriasis
Babakinejad, Parastoo
Lapsley, Rebecca
Foster, Lara
McPherson, Stuart
Pearce, Mark
Reynolds, Nick
Slack, Emma
Weatherhead, Sophie
Hampton, Philip
BRITISH JOURNAL OF DERMATOLOGY, 2023, 188
[39] Ixekizumab in patients with psoriasis and psoriatic arthritis: Pooled analysis of three phase 3 studies in moderate-to-severe psoriasis
Gottlieb, Alice
Papp, Kim
Duffin, Kristina Callis
Birbara, Charles
Cuchacovich, Raquel
Shuler, Catherine
Burge, Russel
Erickson, Janelle
Kerr, Lisa
Mease, Philip
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2015, 135 : S26 - S26
[40] Spotlight on ixekizumab for the treatment of moderate-to-severe plaque psoriasis: design, development, and use in therapy
Giunta, Alessandro
Ventura, Alessandra
Chimenti, Maria Sole
Bianchi, Luca
Esposito, Maria
DRUG DESIGN DEVELOPMENT AND THERAPY, 2017, 11 : 1643 - 1651

← 1 2 3 4 5 →